Chih-Cheng Hung

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Coskun Cetinkaya

> Home > Persons > Chih-Cheng Hung

Publications

2023
[j49]
- view
  authority control:
- export record
  dblp key:
  - journals/bspc/SongZLCH23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bspc/SongZLCH23
Enmin Song, Bangcheng Zhan, Hong Liu, Coskun Cetinkaya, Chih-Cheng Hung:
NMNet: Learning Multi-level semantic information from scale extension domain for improved medical image segmentation. Biomed. Signal Process. Control. 83: 104651 (2023)
2022
[c99]
- view
  authority control:
- export record
  dblp key:
  - conf/brainles-ws/ZhuangLSCH22
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/brainles-ws/ZhuangLSCH22
Yuzhou Zhuang, Hong Liu, Enmin Song, Coskun Cetinkaya, Chih-Cheng Hung:
An Unpaired Cross-Modality Segmentation Framework Using Data Augmentation and Hybrid Convolutional Networks for Segmenting Vestibular Schwannoma and Cochlea. BrainLes@MICCAI (2) 2022: 79-89
[i3]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/corr/abs-2211-14986
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/corr/abs-2211-14986
Yuzhou Zhuang, Hong Liu, Enmin Song, Coskun Cetinkaya, Chih-Cheng Hung:
An Unpaired Cross-modality Segmentation Framework Using Data Augmentation and Hybrid Convolutional Networks for Segmenting Vestibular Schwannoma and Cochlea. CoRR abs/2211.14986 (2022)

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.